Your search returned 3 results.

Results
	1.	A patient with melanoma that became sensitized to immunotherapy after treatment with a CDK4/6 inhibitor. MedStar authors: Alzeer, Ali Hazem Zaemes, Jacob PMID: 32640856 Year: 2020 Citation: Immunotherapy. 12(12):861-867, 2020 08. Institution: MedStar Washington Hospital Center Department: Internal Medicine Residency Pathology Residency Medline publication type: Journal Article Form of publication: Journal Article All authors: Alzeer A, Atkins M, Villa K, Zaemes J DOI: https://dx.doi.org/10.2217/imt-2020-0139 Add to cart (remove)
	2.	The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma. MedStar authors: Abdussamad, Maryam Zapas, John Zhou, Hengbo PMID: 28157711 Year: 2017 Citation: Oncotarget. 8(8):12576-12595, 2017 Feb 21 Institution: MedStar Franklin Square Medical Center Medline publication type: Journal Article Form of publication: Journal Article All authors: Abdussamad M, Atkins MB, Byers SW, Calvert V, Chen YS, Dakshanamurthy S, Fang HB, Gaur A, Petricoin EF, Rosenthal DS, Simbulan-Rosenthal CM, Zapas J, Zhou H DOI: https://dx.doi.org/10.18632/oncotarget.14990 Add to cart (remove)
	3.	Salutary Response to Targeted Therapy in Anaplastic Thyroid Cancer. MedStar authors: Burman, Kenneth D PMID: 31766881 Year: 2019 Citation: Journal of Investigative Medicine High Impact Case Reports. 7:2324709619890942, 2019 Jan-Dec. Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medline publication type: Journal Article Form of publication: Journal Article All authors: Burman KD, Fazeli S, Khosla SG, Maxwell JH, Nylen ES, Paal E DOI: https://dx.doi.org/10.1177/2324709619890942 Add to cart (remove)

Powered by Koha